Papillary intralymphatic angioendothelioma: Dabska tumor.

An Bras Dermatol

Pathological Anatomy Service, Studart & Studart Laboratory, Salvador, BA, Brazil.

Published: May 2020

AI Article Synopsis

  • Papillary intralymphatic angioendothelioma, or Dabska tumor, is a rare lymphatic vascular tumor mainly seen in children and young adults, with fewer than 40 cases reported so far.
  • It typically originates in the soft tissues of the extremities and, while it tends to grow slowly, it can become locally invasive and has the potential to metastasize.
  • A case of a young woman with a 9-month history of a plantar lesion led to a histological diagnosis of Dabska tumor, highlighting the need for its consideration in vascular skin conditions for prompt diagnosis and treatment, along with the importance of long-term follow-up.

Article Abstract

Papillary intralymphatic angioendothelioma (Dabska tumor) is a rarely metastasizing lymphatic vascular neoplasm that usually affects children and young adults. The majority of these cases occur in soft tissues of extremities, and to date less than 40 cases have been described. Despite the generally indolent evolution, can be locally invasive with the potential to metastasize. We describe a case of a young woman presenting with a plantar lesion, for 9 months and histological diagnosis of Dabska tumor. This neoplasm should be considered in the differential diagnosis of vascular dermatoses, allowing early diagnosis and treatment. Long-term follow-up should be performed.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175045PMC
http://dx.doi.org/10.1016/j.abd.2019.03.008DOI Listing

Publication Analysis

Top Keywords

dabska tumor
12
papillary intralymphatic
8
intralymphatic angioendothelioma
8
angioendothelioma dabska
8
tumor papillary
4
tumor rarely
4
rarely metastasizing
4
metastasizing lymphatic
4
lymphatic vascular
4
vascular neoplasm
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!